Mark J. Niciu

Psychiatry

200 Hawkins Dr
Iowa City, IA 52242

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 65 publications

Challenges with clinical trial participants in studies with classical psychedelics: A position statement from the National Network of Depression Centers' task group on psychedelics and related compounds.

Challenges with clinical trial participants in studies with classical psychedelics: A position statement from the National Network of Depression Centers' task group on psychedelics and related compounds.

Journal: Journal of psychopharmacology (Oxford, England)

Published: February 05, 2026

Transcranial magnetic stimulation-associated heart rate decelerations attenuate after a TMS treatment course for depression.

Transcranial magnetic stimulation-associated heart rate decelerations attenuate after a TMS treatment course for depression.

Journal: Brain stimulation

Published: September 05, 2024

Rigor and reproducibility in human brain organoid research: Where we are and where we need to go.

Rigor and reproducibility in human brain organoid research: Where we are and where we need to go.

Journal: Stem cell reports

Published: January 02, 2024

National Network of Depression Centers position statement: Insurance coverage for intravenous ketamine in treatment-resistant major depressive disorder.

National Network of Depression Centers position statement: Insurance coverage for intravenous ketamine in treatment-resistant major depressive disorder.

Journal: Journal of affective disorders

Published: July 18, 2023

Transcranial magnetic stimulation induces heart rate decelerations independent of treatment outcome.

Transcranial magnetic stimulation induces heart rate decelerations independent of treatment outcome.

Journal: Brain stimulation

Published: June 01, 2023

(Es)Ketamine for Suicidal Ideation and Behavior: Clinical Efficacy.

(Es)Ketamine for Suicidal Ideation and Behavior: Clinical Efficacy.

Journal: Chronic stress (Thousand Oaks, Calif.)

Published: June 22, 2022

Biomarkers of ketamine's antidepressant effect: a clinical review of genetics, functional connectivity, and neurophysiology.

Biomarkers of ketamine's antidepressant effect: a clinical review of genetics, functional connectivity, and neurophysiology.

Journal: Chronic stress (Thousand Oaks, Calif.)

Published: March 15, 2021

Neurophysiological Correlates and Differential Drug Response in Subjects With a Family History of an Alcohol Use Disorder.

Neurophysiological Correlates and Differential Drug Response in Subjects With a Family History of an Alcohol Use Disorder.

Journal: Chronic stress (Thousand Oaks, Calif.)

Published: September 13, 2019

Characterizing the course of suicidal ideation response to ketamine.

Characterizing the course of suicidal ideation response to ketamine.

Journal: Journal of affective disorders

Published: June 08, 2018

Clinical Trial of the Potassium Channel Activator Diazoxide for Major Depressive Disorder Halted Due to Intolerability.

Clinical Trial of the Potassium Channel Activator Diazoxide for Major Depressive Disorder Halted Due to Intolerability.

Journal: Journal of clinical psychopharmacology

Published: March 31, 2018

PET radioligand binding to translocator protein (TSPO) is increased in unmedicated depressed subjects.

PET radioligand binding to translocator protein (TSPO) is increased in unmedicated depressed subjects.

Journal: EJNMMI research

Published: March 05, 2018

The effects of cannabidiol (CBD) on cognition and symptoms in outpatients with chronic schizophrenia a randomized placebo controlled trial.

The effects of cannabidiol (CBD) on cognition and symptoms in outpatients with chronic schizophrenia a randomized placebo controlled trial.

Journal: Psychopharmacology

Published: January 23, 2018

Showing 1-12 of 65

Last Updated: 09/26/2026